Copyright © 2000 by the European Society of Cardiology.
Letters to the Editor
Natriuretic peptides in the evaluation of suspected heart failure: studies in primary care are needed
University of Auckland, Auckland, New Zealand
References
- Struthers AD. How to use natriuretic peptide levels for diagnosis and prognosis. Eur Heart J. 1999;20:13741375
[Free Full Text] - Davis M, Espiner E, Richards G. Plasma BNP in assessment of acute dyspnoea. Lancet. 1994;343:440444[CrossRef][ISI][Medline]
- Fleisher D, Espiner E, Yandle T. Rapid assay of plasma BNP in the assessment of acute dyspnoea. NZ Med J. 1997;1039:7174
- Cowie MR, Struthers AD, Wood DA. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997;350:13471351
- Tresch DD, McGough MF. Heart failure with normal systolic function: a common disorder in older people. J Am Geriatr Soc. 1995;43:10351042[ISI][Medline]
- Andersson B, Hall C. N-terminal proANP: a marker of clinically significant diastolic dysfunction (abstr). Eur Heart J. 1999;20:91
- McClure SJ, Caruana L, Davie AP, Goldthorpe S, McMurray J. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic function. BMJ. 1998;317:516519
[Abstract/Free Full Text] - Eur Heart J. 1998;19:9901003
[Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||